发明名称 SYSTEM AND METHOD FOR ADJUSTING THERAPY BASED ON RISK ASSOCIATED WITH A GLUCOSE STATE
摘要 The present disclosure relates to a system and method for determining a basal rate adjustment based on risk associated with a glucose state of a person with diabetes. A method may include detecting a glucose state of the person based on a received glucose measurement signal and determining a current risk metric associated with the detected glucose state. The method may include identifying a reference glucose state and a reference risk metric associated with the reference glucose state, and calculating an adjustment to a basal rate of a therapy delivery device based on the current risk metric associated with the detected glucose state and the reference risk metric associated with the reference glucose level.
申请公布号 US2015273147(A1) 申请公布日期 2015.10.01
申请号 US201414229016 申请日期 2014.03.28
申请人 Roche Diagnostics Operations, Inc. 发明人 Duke David L.;Soni Abhishek S.
分类号 A61M5/172;A61M5/142;G06F19/00 主分类号 A61M5/172
代理机构 代理人
主权项 1. A method of determining a basal rate adjustment based on risk associated with a glucose state of a person with diabetes, the method comprising: receiving, by at least one computing device, a signal representative of at least one glucose measurement; detecting, by the at least one computing device, a glucose state of the person based on the signal, the detected glucose state including a glucose level of the person and a rate of change of the glucose level; determining, by the at least one computing device, a current risk metric associated with the detected glucose state based on a target glucose state, the target glucose state being stored in memory accessible by the at least one computing device, the current risk metric indicating a risk of at least one of a hypoglycemic condition and a hyperglycemic condition of the person; identifying, by the at least one computing device, a reference glucose state and a reference risk metric associated with the reference glucose state; and calculating, by the at least one computing device, an adjustment to a basal rate of a therapy delivery device based on the current risk metric associated with the detected glucose state and the reference risk metric associated with the reference glucose level.
地址 Indianapolis IN US